HIGHLIGHTS OF PRESCRIBING INFORMATION
These highlights do not include all the information needed to use PROTONIX I.V. safely and effectively. See full prescribing information for PROTONIX I.V.
PROTONIX® I.V. (pantoprazole sodium) for injection, for intravenous use
Initial U.S. approval: 2000
RECENT MAJOR CHANGES
INDICATIONS AND USAGE
PROTONIX is a proton pump inhibitor (PPI) indicated in adults for the following:
DOSAGE AND ADMINISTRATION
GERD Associated with EE (2.1)
Pathological Hypersecretion Conditions, Including ZE Syndrome (2.3):
DOSAGE FORMS AND STRENGTHS
WARNINGS AND PRECAUTIONS
Most common adverse reactions (>2%) are: headache, diarrhea, nausea, abdominal pain, vomiting, flatulence, dizziness, and arthralgia. (6.1)
To report SUSPECTED ADVERSE REACTIONS, contact Pfizer Inc. at 1-800-438-1985 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
See the full prescribing information for a list of clinically important drug interactions (7)
USE IN SPECIFIC POPULATIONS
Pregnancy: Based on animal data, may cause fetal harm. (8.1)
See 17 for PATIENT COUNSELING INFORMATION.
PROTONIX® IV (pantoprazole sodium) Highlights
No Current Announcements.
Report an Adverse Event